Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
about
Oxytocin and cardioprotection in diabetes and obesityChronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in ObesityTwo Birds with One Stone: Possible Dual-Role of Oxytocin in the Treatment of Diabetes and OsteoporosisAn essential role for the K+-dependent Na+/Ca2+-exchanger, NCKX4, in melanocortin-4-receptor-dependent satiety.Oxytocin secretion is related to measures of energy homeostasis in young amenorrheic athletes.Serum Irisin and Oxytocin Levels as Predictors of Metabolic Parameters in Obese Children.Oxytocin administration suppresses hypothalamic activation in response to visual food cues.Caffeine inhibits hypothalamic A1R to excite oxytocin neuron and ameliorate dietary obesity in miceOxytocin in the ventromedial hypothalamic nucleus reduces feeding and acutely increases energy expenditure.Oxytocin levels are lower in premenopausal women with type 1 diabetes mellitus compared with matched controls.Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeysOxytocin reduces caloric intake in menSuccessful aging: Advancing the science of physical independence in older adults.The "metabolic sensor" function of rat supraoptic oxytocin and vasopressin neurons is attenuated during lactation but not in diet-induced obesity.Oxytocin Protects against Stress-Induced Cell Death in Murine Pancreatic β-Cells.Chronic CNS oxytocin signaling preferentially induces fat loss in high-fat diet-fed rats by enhancing satiety responses and increasing lipid utilizationOxytocin reduces reward-driven food intake in humans.A New Horizon: Oxytocin as a Novel Therapeutic Option for Obesity and DiabetesOxytocin's inhibitory effect on food intake is stronger in obese than normal-weight menExploring the molecular basis of age-related disease comorbidities using a multi-omics graphical model.The role of oxytocin in cardiovascular regulation.New perspectives on the development of antiobesity drugs.Impact of sex, fat distribution and initial body weight on oxytocin's body weight regulationPopulation Pharmacokinetic Analysis of Vaginally and Intravenously Administered Oxytocin in Postmenopausal Women.Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum.Effects of endogenous oxytocin receptor signaling in nucleus tractus solitarius on satiation-mediated feeding and thermogenic control in male rats.Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients.Central and peripheral control of food intake.Suprachiasmatic Nucleus Neuropeptides and Their Control of Endogenous Glucose Production.Oxytocin enhances cognitive control of food craving in women.Chronic hindbrain administration of oxytocin is sufficient to elicit weight loss in diet-induced obese rats.Effects of Intranasal Oxytocin on the Blood Oxygenation Level-Dependent Signal in Food Motivation and Cognitive Control Pathways in Overweight and Obese Men.Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial.The effects of oxytocin on eating behaviour and metabolism in humans.Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled "future directions for the investigation of intranasal oxytocin and pain".Oxytocin curbs calorie intake via food-specific increases in the activity of brain areas that process reward and establish cognitive control.Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit.Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes.Central insulin action induces activation of paraventricular oxytocin neurons to release oxytocin into circulation.
P2860
Q26748592-F8A43892-916B-48C2-9F38-B744CF60AABDQ26795486-185B460D-F6E7-429F-B2AA-3FB58ED5C20FQ26796207-1B39A262-0452-422E-A33D-D0B0DDA36866Q30403050-FA97A66D-D04E-4CEE-90CA-5613BAFA29FEQ33568999-E789C7A0-B276-4976-8EB1-B3E749F026C5Q33776028-85D3A1F7-39C5-4DF9-82FF-DB3C90E12F02Q33842858-9D6682F6-E1F2-4AC0-93AB-6038A89311F9Q33851226-89C3A2FE-C3A4-49CA-A0FB-CC8D32EDAFE2Q34201138-E9D26C14-39B2-4AE1-BA72-523A9442CA06Q34861560-E6E32718-59D2-4C8D-B7A6-2A5A793F4B68Q35138545-5F07E858-CEE7-4E7F-89C2-0C85D4AB349CQ35554159-8FFB2A9D-F09D-4C9C-8D25-6614702290DCQ36322590-782D5A65-A7A3-49E0-8FB6-B9162ECD0805Q36699850-48FE2D15-8445-463B-A75F-0D48F9A7FE3BQ36864803-CD2AC20D-32AC-4282-A195-1191D83F065CQ36902536-2171F000-45F4-465D-B87A-1C6DE71FA10EQ37193350-4D7C6DB9-953D-4EF9-BD17-C1B76932E914Q37245077-527EB7DF-4C56-4690-A7B7-12AF519C04BAQ37423699-D5EAAE15-38BE-4B32-AD38-9681DC8F2F80Q37439086-4A5828C8-DE8A-4B87-A2FE-51505CFEC86BQ37696788-810CFC7E-A43E-4273-BC66-D2087D85E61AQ38397340-4D7F8E83-1A2C-47B5-A16B-13AA4AFB891DQ38619101-C0FD0456-BE91-4AF6-A3F0-75FCF544EB36Q38692699-237FB344-3CCF-4A90-AD50-F13540ACA741Q38740562-555CA4BB-7133-484F-975A-AD7D9BB68AD8Q38748510-6F50FE45-1CB1-419E-A5EB-9B81D30A87C0Q38810169-49BE634C-8617-4FF0-B002-136648293A15Q39145315-1995B390-8CF4-47A0-A791-5F8C004555B1Q40082525-AA480A20-B334-4FF5-807D-6311757CC8F3Q42098851-DF1A600D-CBAB-41C3-80AB-E7EF522539B9Q46330368-3B8BC9E5-F808-49A1-A07F-3504ED2F5558Q47319904-C47404EF-C747-4AF0-8D56-83EF19222CBEQ47404312-AD190A8A-B749-48E7-88BB-A488793C2A5CQ47902175-4532970C-0064-4FEF-9219-0B102DAFE083Q48819409-C6278412-2F6B-47D6-97BE-18EFCCA1C4C6Q50021001-A8DE53F2-B440-4AA8-A4B4-A6AE55F15112Q52431634-CE45CC4C-1617-4309-9391-5606E6A7FAABQ55337327-7EAA3826-58E8-4FFF-9821-6DC71D96808EQ55647958-0294394B-6544-4EBF-BB15-431017019879
P2860
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@ast
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@en
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@nl
type
label
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@ast
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@en
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@nl
prefLabel
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@ast
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@en
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@nl
P2093
P2860
P921
P1433
P1476
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.
@en
P2093
Chenguang Wu
Dongsheng Cai
Qiaofen Chen
Xiaoluo Chen
Zhigang Xu
P2860
P304
P356
10.1371/JOURNAL.PONE.0061477
P407
P577
2013-05-20T00:00:00Z